Nafcillin-associated hepatotoxicity: Report of a case and review of the literature

Digestive Diseases and Sciences

Volumn 41, Issue 1, 1996, Pages 180-184

  Presti, Michael E ^a   Janney, Christine G ^a   Neuschwander Tetri, Brent A ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

Cholestasis; Hepatotoxicity; Liver diseases; Nafcillin

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; FUROSEMIDE; HEPARIN; NAFCILLIN; OMEPRAZOLE; PREDNISONE; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; CELLULITIS; DRUG HYPERSENSITIVITY; ERYSIPELAS; FEMALE; HISTOLOGY; HUMAN; LIVER INJURY; LIVER TOXICITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STEATOSIS;

CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; LIVER; LIVER DISEASES; MIDDLE AGED; NAFCILLIN;

EID: 0030024315     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02208602     Document Type: Article

References (24)

1. Bruckstein AH, Attia AA: Oxacillin Hepatitis. Am J Med 64:519-522, 1978
2. Dismukes WE: Oxacillin-induced hepatic dysfunction. JAMA 266:861-863, 1973
3. Klein I, Lillel T: Oxacillin-associated hepatitis. Am J Gastroenterol 65:546-547, 1976
4. Olans RN, Weiner LB: Reversible oxacillin hepatotoxicity. J Pediatr 89:835-838, 1976
5. Onorato IM, Axelrod JL: Hepatitis from intravenous high-dose oxacillin therapy. Ann Intern Med 89:497-500, 1978
6. Pollock AA, Berger SA, Simberkoff MS, Rahal JJ: Hepatitis associated with high-dose oxacillin therapy. Arch Intern Med 138:915-917, 1978
7. Taylor C, Corrigan K, Steen S, Craig C: Oxacillin and hepatitis. Ann Intern Med 90:857-858, 1979
8. Ten Pas A, Quinn EI: Cholestatic hepatitis following the administration of sodium oxacillin. JAMA 191:138-139, 1965
9. Bass NM, Ockner RK: Drug-induced liver disease. In Hepatology. D Zakim, TD Boyer (eds). Philadelphia, WB Saunders, 1990, pp 754-791
10. Miller WI, Souney PF, Chang JT: Hepatic dysfunction following nafcillin and cephalothin therapy in a patient with a history of oxacillin hepatitis. Clin Pharmacol 2:465-468, 1983
11. Bengtsson F, Floren CH, Hagerstrand I, Soderstrom C, Aberg T: Flucloxacillin-induced cholestatic liver damage. Scand J Infect Dis 17:125-128, 1985
12. Enat R, Pollack S, Ben-Arieh Y, Livini E, Barzilai D: Cholestatic jaundice caused by cloxacillin: macrophage inhibitor factor test in preventing rechallenge with hepatotoxic drugs. BMJ 260:982-983, 1980
13. Goldstein LI, Ishak KG: Hepatic injury associated with penicillin therapy. Arch Pathol 98:114-117, 1974
14. Kleinman MS, Presberg JE: Cholestatic hepatitis after dicloxacillin-sodium therapy. J Clin Gastroenterol 8:77-78, 1986
15. Konikoff F, Alcalay J, Halevy J: Cloxacillin-induced cholestatic jaundice. Am J Gastroenterol 81:1082-1083, 1986
16. Lobatto S, Dijkmans B, Mattie H, Van Hooff JP: Flucloxacillin-associated liver damage. Neth J Med 24:47-48, 1982
17. Tauris P, Jorgensen NF, Petersen CM, Albertsen K: Prolonged severe cholestasis induced by oxacillin derivatives. Acta Med Scand 217:567-569, 1985
18. Lestico MR, Vick KE, Hetsko CM: Hepatic and renal dysfunction following nafcillin administration. Ann Pharmacother 26:985-990, 1992
19. Mazuryk H, Kastenberg D, Rubin R, Munoz S: Cholestatic hepatitis associated with the use of nafcillin. Am J Gastroenterol 88:1960-1962, 1993
20. Ryan J, Dudley FJ: Cholestasis with ticarcillin-potassium clavulanate (Timentin). Med J Aust 156:291, 1992
21. Schwartz MS, Frank MS, Yanoff A, Morecki R: Atenolol-associated cholestasis. Am J Gastroenterol 84:1084-1086, 1989
22. Wong FS, Ryan J, Dabkowski P, Dudley FJ, Sewell RB, Smallwood RA: Augmentin-induced jaundice. Med J Aust 154:698-701, 1991
23. Eng C, Javitt NB: Effect of nafcillin on hepatic excretory function. Biochem Pharmacol 32:3649-3651, 1983
24. Aderka D, Livini E, Salamon F, Weinberger A, Pinkhas J: Use of macrophage inhibition factor and mast-cell degranulation tests for diagnosis of cloxacillin induced cholestasis. Am J Gastroenterol 81:1084-1086, 1986